Agenda
International Congress on Oncology Research and Development
05 October 2019, Day 1 (Saturday)
| Time | Topic | Confirmed/Proposed Speakers |
|---|---|---|
| 08:00–09:00 | Registration | |
| 09:00–09:05 | Congress Welcome | Dr K Govind Babu, HCG, Bangalore |
| 09:05–09:10 | Lamp lighting ceremony and formal opening of conference | Dr Indu Bhushan, CEO, Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), NHA, Delhi Representatives from Scientific Advisory Board of ICORD: Dr K Govind Babu, HCG, Bangalore Dr G S Bhattacharya, SLCMC, Kolkatta Dr Aung Myo, Tessa Therapeutics, Singapore Dr Chirag Desai, VIMS, Ahmedabad Dr Chandragouda Dodagoudar, BLK, Delhi Dr Manoj Kumar Sharma, Fortis Noida Dr. Shailesh A Bondarde, Shatabdi SSH, Nashik Dr Chetan Deshmukh, DMH, Pune Dr Dinesh C Doval, RGCIRC, Delhi ICORD organizing committee |
| 09:10–09:20 | Ayushman Bharat – PM-JAY | Dr Indu Bhushan, CEO, Ayushman Bharat |
| 09:20–09:30 | National Cancer Grid | Dr C S Pramesh, TMH, Mumbai |
| 09:30–09:40 | Developing Cancer control and Cancer Research | Dr Rajiv Sarin, TMH, Mumbai |
| 09:40–10:00 | Panel Discussion | |
| 10:00–10:20 | Cancer Scenario in Nepal and SAARC Countries : Challenges and Solutions | Prof. R P Baral Chairman, SAARC Federation Of Oncologist (SFO), Nepal |
| 10:20–10:40 | Panel Discussion: Defeating Cancer – Patient perspective | Moderator: Dr Meenu Walia, Maxhealthcare, Delhi Viji Venkatesh, Friends of Max, Mumbai Sneha Routray, Gramin Sneh Foundation Megha Ahuja, Sashakt Foundation Dr Shikha Darbari, IRS, Survivor, Rajya Sabha Poonam Jha – Survivor Vivek Tomar, Rise to survive cancer, Delhi Sandy Singh, Caregiver |
| 10:40–10:50 | Networking and Refreshment Break | |
| 10:50–11:00 | Chemotherapy | Dr Chandragouda Dodagoudar, BLK, Delhi |
| 11:00–11:10 | Targeted Therapy | Dr K Govind Babu, HCG, Bangalore |
| 11:10–11:20 | Immunotherapy | Dr Vineet Talwar, RGCIRC, Delhi |
| 11:20–11:50 | Panel discussion | Dr K Govind Babu, HCG, Bangalore Dr Dinesh C Doval, RGCIRC, Delhi Dr Vineet Talwar, RGCIRC, Delhi Dr Navneet Singh – PGIMER, Chandigarh |
| 11:50–11:55 | Introduction and overview | Dr G S Bhattacharyya, SLCMC, Kolkatta |
| 11:55–12:03 | Relevance of Biomarker testing in Immune Therapy< | Dr Hemant Malhotra, SRCC, Jaipur |
| 12:03–12:11 | Issues in identifying biomarkers | Dr Moushumi Suryavanshi, RGCIRC, Delhi |
| 12:11–12:19 | Beyond Checkpoint inhibitors | Dr S.V. Chiplunkar, TMH, Mumbai |
| 12:19–12:50 | Panel Discussion< | Moderator- Dr G S Bhattacharyya Dr Hemant Malhotra, SRCC, Jaipur Dr Moushumi Suryavanshi, RGCIRC, Delhi Dr S.V. Chiplunkar, TMH, Mumbai |
| 12:50–13:50 | Luncheon | |
| 13:50–14:03 | International perspective | Dr Harit Chaturvedi, Max Healthcare, Delhi |
| 14:03–14:16 | Indian perspective | Dr Anil D’cruz, UICC/ TMH, Mumbai |
| 14:16–14:20 | Q&A | |
| 14:20–15:05 | HCC – An Asian disease | Moderator: Prof Peirce Chow, Singapore Dr Ashok Choudhuri, ILBS, Delhi Dr Meenu Walia, Max Healthcare, Delhi |
| 15:05–15:15 | Stem cell therapyy | Dr BN Manohar, CEO, Stempeutics, Bangalore |
| 15:15–15:25 | CAR T Cell Therapy | Prof Rahul Purwar, ImmunoACT, Mumbai |
| 15:25–15:35 | T-cell therapy | Dr Aung Myo, Tessa Therapeutics, Singapore |
| 15:35–15:50 | Panel Discussion | Dr BN Manohar, Dr Aung Myo, Ms Zoya Brar, Core Diagnostics, Delhi |
| 15:50-16:05 | Networking and Refreshment Break | |
| 16:05–16:15 | Introduction of session + Overview | Dr Anurag Mehta |
| 16:15–16:25 | Use and limitations of CTCs/CT DNA | Dr Amit Verma, Max Hospital, Delhi |
| 16:25–16:35 | Genomic testing | Dr Sushant Vinarkar, Metropolis, Mumbai |
| 16:35–16:45 | Clinical Perspective/relevance of liquid biopsy | Dr Chetan Deshmukh, DMH, Pune |
| 16:45–17:00 | Panel Discussion | All |
| 17:00–17:45 | Panel Discussion: Affordable Cancer Therapy Treating cancer 100Rupees a day |
Moderator: Dr GS Bhattacharyya Dr Ravi Kannan, CCH, Assam, Dr Shripad D Banavali, TMH, Mumbai Dr Rajesh Kantharia, KCHRC, Gujrat |
| 17:45-18:00 | Adjourn/Break | |
| 18:00-19:30 | Networking Reception followed by dinner | |
06 October 2019, Day 2 (Sunday)
| Time | Topic | Confirmed/Proposed Speakers |
|---|---|---|
| 09:00–09:10 | Summary of Day-1 and agenda for day 2 | Dr K Govind Babu, HCG, Bangalore |
| 09:10–09:40 | Cell Based Therapies – Asian Landscape | Dr Aung Myo, Tessa Therapeutics, Singapore |
| 09:40–10:00 | Bioethics in CAR-T Cell therapy | Dr Chirag Desai, VIMS Ahmedabad |
| 10:00–10:20 | Complexities and Management of Personalized medicine supply chain | Serene Ong, Marken, Singapore |
| 10:20-10:45 | Challenges and Opportunities for Asian Biotech’s in developing new cancer therapies | Dr S K Vakkalanka, Incozen Therapeutics, Hyderabad Prof Rahul Purwar, ImmunoACT, Mumbai |
| 10:45-11:00 | Networking and Refreshment Break | |
| 11:00–11:20 | Debate: Proton vs Photon in radiation therapy | Moderator: Dr Rajiv Sarin –TMH, Mumbai Dr Srinivas Chilkuri, Apollo Chennai Dr Manoj Kumar Sharma, Fortis Noida Dr Tejinder Kataria, Medanta, Gurgaon Dr PK Sharma, Fortis, Noida |
| 11:20–11:40 | Radiopharmaceuticals – Alfa therapy/ /Targeted radio therapy |
Dr Vikram Lele, Jaslok Hospital, Mumbai |
| 11:40-12:00 | Artificial intelligence role in radiology | Dr Jayadeepa S, Image Core Labs, Bangalore |
| 12:00-13:00 | Focused session on Lymphoma and Leukemia – Overview of Treatment Landscape,Current and emerging treatment options |
Dr Lalit Kumar, AIIMS, Delhi Dr. T.S.Ganesan, CRCI (WIA), Chennai Dr Manju Sengar, TMH, Mumbai Dr Prashant Ganeshan, JIPMER, Puducherry Dr S K Vakkalanka, Incozen Therapeutics, Hyderabad |
| 13:00–14:00 | Luncheon | |
| 14:00–14:10 | From Generics to Biosimilars – shifting landscape – Outlook for India’s Biosimilar development Market | Dr Neera Gupta |
| 14:10–14:20 | Clinical Development Strategy for Biosimilars | Dr Shubhadeep Sinha, Hetero Labs, Hyderabad |
| 14:20–14:30 | Global developments and APAC scenario | Suhail Ali, Singapore |
| 14:30–14:40 | Clinical acceptance of Biosimilars | Dr. Shailesh A Bondarde, Shatabdi SSH, Nashik |
| 14:40–15:00 | Panel Discussion | All |
| 15:00–15:10 | Introduction and overview of the session | Dr Manish Mistry |
| 15:10–15:20 | India’s Clinical Trials Regulations Reform | Dr V G Somani, DCGI, Delhi |
| 15:20–15:30 | Umbrella, basket and platform trials | Suhail Ali, Singapore |
| 15:30–15:40 | Collaborative Research trials in India | Dr Chirag Desai, VIMS, Ahmedabad |
| 15:40–16:00 | Panel Discussion | Dr Manish Mistry, Dr V G Somani, Suhail Ali, Dr Ajit Nair, Dr Chirag Desai |
| 15:45–16:00 | Networking Reception | |
| 16:00–16:20 | Role of Patient advocacy groups in Cancer care | Moderator: Viji Venkatesh, Friends of Max, Mumbai Prabhat Sinha, Novartis Oncology, Bangalore Vivek Tomar, Rise to survive cancer, Delhi |
| 16:20-16:40 | Supportive care in Oncology – Palliative care – Pain control |
Dr Reena Sharma, Can Support, Delhi |
| 16:40–17:00 | Closing Remarks | |
| 17:00 onwards | End of Conference and Departure | |